Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance - sprookjes - yvandenbroek - TriplyDB

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

http://www.wikidata.org/entity/Q33372590

about

BMPR2 LCL 172 BMPR2 LCL 176 BMPR2 LCL 180 BMPR2 LCL 186 BMPR2 LCL 264 BMPR2 LCL 266 BMPR2 LCL 723

P1343

Microarray analysis in pulmonary hypertension The genetics of pulmonary arterial hypertension Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension Pulmonary arterial hypertension: the clinical syndrome.Sex differences in the pulmonary circulation: implications for pulmonary hypertension The imitation game in pulmonary arterial hypertension. Sex, bone morphogenetic protein receptor, and the estrogen paradox Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension Heritable forms of pulmonary arterial hypertension.Role of BMPR2 alternative splicing in heritable pulmonary arterial hypertension penetrance.Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene Pulmonary hypertension in women.Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.Pulmonary arterial hypertension: insights from genetic studies.Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.The genetics of pulmonary arterial hypertension in the post-BMPR2 era.Epigenetic mechanisms of pulmonary hypertension.Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression.BMPR2 expression is suppressed by signaling through the estrogen receptor.Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming.Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.Gender, sex hormones and pulmonary hypertension.Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension A process-based review of mouse models of pulmonary hypertension.Genomics and proteomics of pulmonary vascular disease.Genetics and the molecular pathogenesis of pulmonary arterial hypertension.Progress in solving the sex hormone paradox in pulmonary hypertension.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Molecular pathogenesis and current pathology of pulmonary hypertension.

P2860

Q54797640-33DCE28C-60F1-4D7F-BE03-EAE3991EA4F0 Q54797642-2ADD6A3A-BC28-4BDF-9DAC-DAC716D038FA Q54797643-6F4BCB84-BB97-4B29-9BA6-A29C9B6A2D58 Q54797644-0B379EBF-0D3D-4496-BEC5-AF2A85918B05 Q54797645-DC1ECBD5-9A2C-461E-A5B3-E9EB33498545 Q54797646-1A4FD428-0114-4E93-BE3D-150A90830846 Q54797648-9009891A-DE29-4826-95CD-F352F39F9FD0

P1343

Q26748607-C499B8A6-07B6-4780-B342-10100CF97C63 Q27027507-BD86AA28-7B4D-48DB-B7DF-1CEDAE84E82D Q28078976-E407C9E9-E9EE-4AC6-96C0-97EE6656F347 Q28534831-A6ED2127-ACBF-4BEC-B0F6-05107F62A744 Q30583630-C22830E0-A066-4140-A1B6-2CEC56AE7C97 Q33568826-28AAAE74-C6A8-41EA-B082-9FCA78F0EC41 Q33723029-7E916BF3-358E-42C3-BFE2-0AF74CD85739 Q33786374-4F7A3CDF-F8F3-46C2-B80C-6CC2CE449192 Q33806083-411BC8C7-22D9-4D7C-B6A8-03AC45D4C573 Q33915567-E6F54253-D1C4-4EBC-948F-32D2423839C6 Q33959437-81497EAC-5ABB-45D5-B00D-7D89586897CE Q33968765-17BDBF49-75D1-40A2-AF39-F9D330AB1457 Q33970081-36A5C015-8378-40BF-AF64-4CE08494B29B Q34130859-D7395EC5-8393-47DC-B3F4-B22152098AC5 Q34576173-EC7A881F-AE6C-4A4B-9F9F-763D96BAD675 Q34795939-C877C933-BE2C-48FA-9B34-F96E706A9BDA Q34973575-060E08C7-AE43-4732-A791-F343B2185FC1 Q35019516-7810A691-9060-415D-BA70-0D2C483E0934 Q35092474-88282BD7-393B-4394-BA57-1109692557BB Q35262038-76B27ACB-5C85-4367-90CE-D151667E4C82 Q35573919-B98E0EB3-A6A2-401C-A69C-EB1961F6525A Q35573935-AD64229C-61F3-4A92-8742-01D78EDAF0C7 Q35573948-2A9D3791-DD99-4555-94C9-C0594276DD8D Q35848094-1D3A6C16-76BC-4BB1-94C8-EDC81705286C Q35850232-22F90664-FFBF-49F7-BF30-FAD464FBF9D2 Q36108056-BDD8CB43-B201-4B7C-8A69-DA8E6933EC0D Q36110556-D2B08878-4D44-44BF-82B2-53DE81BEFEEE Q36421287-4C773CAC-4762-43DC-B939-ABF71A32BBD4 Q36769101-51F09334-1C25-4DBF-B5FC-FEF2B5E0CC9D Q36881746-D9239577-0419-4846-B136-755097DC64BA Q36943390-DAB3451B-E2A2-4C78-BC68-8361685407AB Q37091591-C47858C4-5D82-4608-861A-16A00E8A7622 Q37133789-FD23F37F-9867-476A-ADD3-F25CD794EE22 Q37162337-A7DE4810-B4CF-45F5-A736-39F3F9391994 Q38078369-94F22B60-BD50-41D8-8FFE-03A7CDF3C75C Q38112045-6F2A9898-8DE2-4BB8-A0DB-638EF509B1C6 Q38146987-6384DE38-C9B6-4A8B-9C91-ABE5875FEFB9 Q38210880-705DCACB-CF13-4303-9ED9-2BFC297AA4B1 Q38642429-1D0EFFF8-A51D-4B4A-9ED9-DBE8BA129265 Q38676413-3817C0CA-5271-461C-8DB8-DA487B6728E4

P2860

Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance

http://www.wikidata.org/entity/Q33372590

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@ast

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@en

type

label

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@ast

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@en

prefLabel

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@ast

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@en

P1433

Q33372590-5255E5E6-FB47-4F05-B0AA-8B628ED19F5C

P1476

Q33372590-D0BCB0D8-648F-4A5D-B3E6-6A4856660305

P2093

Q33372590-20049FD6-1077-41DE-8985-E1AEFED159B5

Q33372590-2F18D6EB-D45B-40C3-9F8B-E71AF558F41E

Q33372590-6DA59F8A-2AB6-4916-84A0-0F8EC559DD8E

Q33372590-8651BA58-3BEE-44A4-BBCB-299D660E71BE

Q33372590-97593504-6CAF-4311-A900-3407607307AF

Q33372590-BF57D210-5AF4-457E-A5A8-35A9C34527CA

Q33372590-F51E02E2-BDB7-4642-B715-DE9602D2EB75

P2860

Q33372590-0125C3DF-11DD-4FA6-BF06-BFBD2C68172E

Q33372590-1A577016-2A7F-4058-8C26-BD60C2941542

Q33372590-1D283106-223F-4110-AD00-5967D48F372B

Q33372590-20CDCF9C-503D-4C7A-B1CA-76C596B000F3

Q33372590-2B50971C-1E37-4A29-9B3D-4EDB32D2F190

Q33372590-2B980C84-994D-440A-B6AC-B768448DEC2E

Q33372590-2E7FDD90-7201-4E87-9DD4-A57D29220162

Q33372590-3B4A52B9-57C9-49E7-B013-7FE6D2B1A3C8

Q33372590-3B93903E-B3E4-439B-A2E1-B9EBDAACC357

Q33372590-3E41F184-8E94-4FF9-AA87-2A04FF0CF16D

P2888

Q33372590-B0973DD3-2597-4148-B558-0149733C1D67

P304

Q33372590-F32D3B14-4395-4AA8-84F6-418D0B19D1C8

P31

Q33372590-7BEA6D97-A386-4482-A8F9-7A15EC2C69EC

P356

Q33372590-DAD7FBEB-D0F3-46FB-AF3A-AD236D040533

P4510

Q33372590-122AEC95-12B9-496F-A87A-C8EF589CBE2A

Q33372590-3CF46767-F0B7-4D5B-ACAC-20ADF108C7C2

Q33372590-3DE9BD5C-FCB8-4A27-8EE7-103FCF56A77D

Q33372590-3FC4C1C1-36ED-49F5-B432-8D67D15A39AD

Q33372590-71CC5B8C-3F67-44C9-9B5B-AD4F0523EE00

Q33372590-9AD2A03E-FB35-429A-B985-8F60E5DE4532

Q33372590-E1F3BA76-4750-4275-A870-39E7AA28A049

P478

Q33372590-1C75F3D9-DC8F-43A4-A1CB-1955EA0140F8

P50

Q33372590-07699365-4435-4040-A917-2B8E31FB967C

Q33372590-3A006DF4-6D7D-4691-BB7B-31C7A69CBFC5

P577

Q33372590-BEC0D957-A580-423C-8D19-20387B52C2E6

P5875

Q33372590-4A997C43-BFE0-4E6D-A853-6A57C9FEAE1D

P6179

Q33372590-AE713528-36C2-4C9D-8176-F88524B5AF23

P698

Q33372590-550D863F-E43E-4CDA-8D54-2C94699C47C1

P921

Q33372590-FF406E41-7D70-4E2E-B15E-B2B3B314959C

P932

Q33372590-614AB05C-94BB-4023-AC6E-3063EA39E694

P356

P1433

BMC Medical Genomics

P1476

Gene expression in BMPR2 mutat ...... relevant to disease penetrance

@en

P2093

Barbara Meyrick

http://www.w3.org/2001/XMLSchema#string

Jim Loyd

http://www.w3.org/2001/XMLSchema#string

John A Phillips

http://www.w3.org/2001/XMLSchema#string

Joy Cogan

http://www.w3.org/2001/XMLSchema#string

Kirk Lane

http://www.w3.org/2001/XMLSchema#string

Linda Robinson

http://www.w3.org/2001/XMLSchema#string

Mark Geraci

http://www.w3.org/2001/XMLSchema#string

P2860

The Gene Ontology (GO) project in 2006

Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection

Primer3 on the WWW for general users and for biologist programmers

Systematic determination of genetic network architecture

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2)

Constitutive expression and induction of CYP1B1 mRNA in the mouse

A genome-wide association study of global gene expression

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Proteomics of transformed lymphocytes from a family with familial pulmonary arterial hypertension.

P2888

P304

45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-8794-1-45

http://www.w3.org/2001/XMLSchema#string

P4510

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

James David West

P577

2008-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23286862

http://www.w3.org/2001/XMLSchema#string

P6179

1026772541

http://www.w3.org/2001/XMLSchema#string

P698

18823550

http://www.w3.org/2001/XMLSchema#string

P921

P932

2561034

http://www.w3.org/2001/XMLSchema#string